A 2017 survey from the public opinion research firm Public Opinion Strategies found that nearly three-quarters of Americans had seen TV ads by attorneys warning about the dangers of certain pharmaceuticals. It turns out, the Federal Trade Commission has watched these ads too, and it doesn’t always like what it sees.

Letters recently obtained by ALM show that several law firms and legal marketers across the country received warning letters in September over TV ads they were airing about allegedly dangerous medications that are now the subject of mass tort litigation. And, according to an FTC attorney, those letters were part of a new initiative by the agency aimed at keeping an eye on legal ads that may be alarming for viewers and could potentially lead them to stop taking their prescribed medications.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]